Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects

被引：0
作者：
Chanan Shaul
Simcha Blotnick
Mordechai Muszkat
Meir Bialer
Yoseph Caraco
机构：
[1] Hadassah-Hebrew University Medical Center,Clinical Pharmacology Unit, Division of Medicine
[2] Hebrew University,Institute of Drug Research, School of Pharmacy, Faculty of Medicine
来源：
Molecular Diagnosis & Therapy | 2017年 / 21卷
关键词：
Warfarin; Variant Allele; Warfarin Dose; Oral Clearance; CYP2C9 Genotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 83
页数：8
相关论文
共 50 条
  • [21] Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
    Schwarz, UI
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 23 - 30
  • [22] Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism
    King, BP
    Khan, TI
    Aithal, GP
    Kamali, F
    Daly, AK
    PHARMACOGENETICS, 2004, 14 (12): : 813 - 822
  • [23] Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose
    Gin Gin Gan
    Alan Teh
    Vijaya Sangkar
    Maude Elvira Phipps
    Chee Seng Ku
    International Journal of Hematology, 2004, 80 : 295 - 296
  • [24] CYP2C9 polymorphism affects warfarin complications
    Reactions Weekly, 1999, 741 (1) : 4 - 4
  • [25] Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals
    Elena García-Martín
    Carmen Martínez
    José M. Ladero
    José A. G. Agúndez
    Molecular Diagnosis & Therapy, 2006, 10 : 29 - 40
  • [26] Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation
    Zhang, ZY
    Kerr, J
    Wexler, RS
    Li, HY
    Robinson, AJ
    Harlow, PP
    Kaminsky, LS
    THROMBOSIS RESEARCH, 1997, 88 (04) : 389 - 398
  • [27] Effect of CYP2C9*2 and VKORC-1639G/A Polymorphisms on Warfarin Doses Requirements in Sudanese Patients
    Elsadig, Ahmed Elhadi
    Muddath, Abdel Rahim M.
    Elamin, Elwaleed M.
    Shrif, Nasr Eldin Ma
    Waggiallah, Hisham Ali
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (07) : 1366 - 1373
  • [28] Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients
    Zhang, Suli
    Zhao, Mingzhe
    Zhong, Shilong
    Niu, Jiamin
    Zhou, Lijuan
    Zhu, Bin
    Su, Haili
    Cao, Wei
    Xing, Qinghe
    Yan, Hongli
    Han, Xia
    Fu, Qihua
    Li, Qiang
    Chen, Luan
    Yang, Fan
    Zhang, Na
    Wu, Hao
    He, Lin
    Qin, Shengying
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (04) : 105 - 116
  • [29] Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
    Jia, LiQun
    Wang, Zanxin
    Men, Jianlong
    Cai, Heng
    Wei, Minxin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 421 - 425
  • [30] The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Bedewy, Ahmed M. L.
    Showeta, Salah
    Mostafa, Mostafa Hasan
    Kandil, Lamia Saeed
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 328 - 336
12345